Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma

Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma

Objective: Whole-body I-131 scanning (WBS) is a standard method in the evaluation of patients with differentiated thyroid carcinoma (DTC). However, it has some limitations in terms of distinguishing between physiological and pathological tracer uptake and in defining the exact anatomical location of...

Full description

Bibliographic Details
Main Author:	Sibel Uçak Semirgin
Format:	Article
Language:	English
Published:	KARE Publishing 2020-01-01
Series:	Erciyes Medical Journal
Subjects:	differentiated thyroid carcinoma 131-i spect.
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=erciyesmedj&un=EMJ-75010

Similar Items

Restaging of differentiated thyroid carcinoma with SPECT/CT after radioiodine therapy
by: Mariya Alekseevna Karalkina, et al.
Published: (2015-07-01)

Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study
by: Angela Spanu, et al.
Published: (2020-03-01)

The clinical significance of remnant thyroid tissue in thyroidectomized differentiated thyroid cancer patients on 131I-SPECT/CT
by: Feng Wang, et al.
Published: (2021-05-01)

The Diagnostic Usefulness of <sup>131</sup>I-SPECT/CT at Both Radioiodine Ablation and during Long-Term Follow-Up in Patients Thyroidectomized for Differentiated Thyroid Carcinoma: Analysis of Tissue Risk Factors Ascertained at Surgery and Correlated with Metastasis Appearance
by: Angela Spanu, et al.
Published: (2021-08-01)

The Value of Pre-Ablative I-131 Scan for Clinical Management in Patients With Differentiated Thyroid Carcinoma
by: Trynke van der Boom, et al.
Published: (2021-05-01)

Differentiated Thyroid Carcinoma and Late Onset of Lung Distant Metastasis. A Case Report
by: Alessandro Semprebene, et al.
Published: (2019-02-01)

Long-Term Prognostic Value of the Response to Therapy Assessed by Laboratory and Imaging Findings in Patients with Differentiated Thyroid Cancer
by: Michele Klain, et al.
Published: (2021-08-01)

“Tumour sink effect” on the diagnostic or posttreatment radioiodine scan due to sequestration into large-volume functioning metastasis of differentiated thyroid carcinoma influencing uptake in smaller metastatic sites or remnant thyroid tissue: An uncommon but possible phenomenon in thyroid cancer practice
by: Sandip Basu, et al.
Published: (2020-01-01)

Efficacy and Affecting Factors of 131I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma
by: Chen Wang, et al.
Published: (2018-12-01)

Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?
by: Elizabeth J. de Koster, et al.
Published: (2021-03-01)

Iodine 131 ablation of an obstructive lingual thyroid
by: Lester Johnson, et al.
Published: (2009-01-01)

Evaluation of SNA001, a Novel Recombinant Human Thyroid Stimulating Hormone Injection, in Patients With Differentiated Thyroid Carcinoma
by: Yushen Gu, et al.
Published: (2021-02-01)

The Study of External Dose Rate and Retained Body Activity of Patients Receiving 131I Therapy for Differentiated Thyroid Carcinoma
by: Haiying Zhang, et al.
Published: (2014-10-01)

Predictivity of stimulated serum thyroglobulin and antithyroglobulin antibodies for the efficacy of thyroid remnant ablation on patients with differentiated thyroid carcinoma
by: Narin Nasiroglu Imga, et al.
Published: (2016-12-01)

Unusual false positive radioiodine uptake on 131 I whole body scintigraphy in three unrelated organs with different pathologies in patients of differentiated thyroid carcinoma: A case series
by: Rohit Ranade, et al.
Published: (2016-01-01)

Original paper<br>Effects of absorbed dose of 131I isotope on the effectiveness of ablation of thyroid remnant tissue
by: Zbigniew Adamczewski, et al.
Published: (2007-06-01)

Unusual sites of metastatic and benign I 131 uptake in patients with differentiated thyroid carcinoma
by: Shanmuga S Palaniswamy, et al.
Published: (2018-01-01)

Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment
by: Michele Klain, et al.
Published: (2019-03-01)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
by: Chae Moon Hong, et al.
Published: (2017-10-01)

Thyroid hormone replacement one day before 131I therapy in patients with well-differentiated thyroid cancer
by: Daiki Kayano
Published: (2013-04-01)

Thyroid hormone replacement one day before 131I therapy in patients with well-differentiated thyroid cancer
by: Daiki Kayano, et al.
Published: (2013-04-01)

Evaluation of Discordance in Differentiated Thyroid Cancer Patients with Negative Radioiodine Scans and Positive Thyroglobulin Values at the Ablation Outcome Control
by: Zeynep Gözde Özkan, et al.
Published: (2012-03-01)

SPECT and planar γ-camera imaging for volume and activity determination of I131 sources applying threshold technique
by: Μπαρμπαγιαννίδης, Προκόπιος
Published: (2009)

Evaluation of Iodine-123 and Iodine-131 SPECT activity quantification: a Monte Carlo study
by: Michaella Morphis, et al.
Published: (2021-08-01)

Clinical features of bone metastasis for differentiated thyroid carcinoma: A study of 21 patients from a Tunisian center
by: Faouzi Kallel, et al.
Published: (2014-01-01)

Radionuklidna terapija bolesnika sa regionalnim i udaljenim metastazama diferenciranog karcinoma štitaste žlezde
by: Mihailović Jasna
Published: (2011-01-01)

The Effect of Hypothyroidism on Liver Function in Patients with Differentiated Thyroid Cancer After Operation Before 131I-Treatment
by: ZHANG Hui;DUAN Dong
Published: (2018-02-01)

The minimum amount of fluids needed to achieve the fastest time to reach permissible level for release in well-differentiated thyroid patients undergoing high-dose I-131 therapy
by: Alex Khoo Cheen Hoe, et al.
Published: (2018-01-01)

Comparison of Clinical and Ultrasonographic Features of Poorly Differentiated Thyroid Carcinoma and Papillary Thyroid Carcinoma
by: Bo Zhang, et al.
Published: (2016-01-01)

Multiple Bone Metastases in a Patient with Differentiated Thyroid Cancer (DTC) : Complete resolution following thyroidectomy and four ablation doses of I-131
by: Omayma T Elshafie, et al.
Published: (2010-04-01)

The diagnostic usefulness of FDG-PET/CT in detecting tumor recurrence not evident in whole body I131 scan in differentiated thyroid carcinoma
by: Maged Abdel Galil Hamed, et al.
Published: (2014-06-01)

Adequate duration and modality of follow-up for patients treated with 131 I for differentiated thyroid cancer
by: Adedapo, Kayode Solomon
Published: (2009)

Comparison of whole body 131Iodine scan results in four, seven and nine days after radio-iodine therapy of differentiated thyroid cancer
by: Kamran Aryana, et al.
Published: (2019-04-01)

Can we safely reduce the administration of 131-iodine in patients with differentiated thyroid cancer? – experience of the Brugmann hospital in Brussels
by: Laura Iconaru, et al.
Published: (2020-09-01)

Comportamento da tireoglobulina serica em pacientes portadores de carcinoma de tireoide tratados com I-131
by: VITERBO, BEATRIZ G.
Published: (1988)

Comportamento da tireoglobulina serica em pacientes portadores de carcinoma de tireoide tratados com I-131
by: VITERBO, BEATRIZ G.
Published: (1988)

Pharmacokinetics of gene recombined angiogenesis inhibitor Kringle 5 in vivo using 131I specific markers and SPECT/CT
by: Ge Yan, et al.
Published: (2016-10-01)

Follicular thyroid carcinoma metastasizing to rare sites and exhibiting variable inter-lesional heterogeneity on 18F-fluorodeoxyglucose positron emission tomography/computed tomography and 131I
by: Rahul V Parghane, et al.
Published: (2021-01-01)

Malignant Struma ovarii in a 30-year old nulliparous patient
by: J. Colin Boyd, et al.
Published: (2017-05-01)

POSTRADIAL SIALOZOADENITIS IN PATIENTS WITH PAPILLARY CARCINOMA OF THE THYROID GLAND
by: V. A. Kovalenko, et al.
Published: (2015-02-01)